STAT+: Cancer patient who devoted six years to drug pricing reform isn’t done yet

BETHESDA, Md. — After six years of relentless advocacy work, David Mitchell was finally on the cusp of defeating his Goliath — the pharmaceutical industry.

He sat at his desk cranking through his inbox on Friday afternoon, while lawmakers debated a bill he had helped push, the biggest prescription drug pricing reform in two decades. He found yet another interview request at the top. This time, it was from Good Morning America.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Cancer patient who devoted six years to drug pricing reform isn’t done yet »